Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1981 Jul 25;283(6286):265–267. doi: 10.1136/bmj.283.6286.265

Deep venous thrombosis of the arm: a study of coagulation and fibrinolysis.

S B Sundqvist, U Hedner, H K Kullenberg, S E Bergentz
PMCID: PMC1506326  PMID: 6788281

Abstract

Sixty consecutive patients with phlebographically verified deep venous thrombosis of the upper arm were studied for disorders of coagulation and fibrinolysis. No appreciable increase in abnormalities of the factor VIII complex, antithrombin III, or inhibitors of activators of fibrinolysis were found. A decreased fibrinolytic defence mechanism, evident either as a deficient release capacity of fibrinolytic activators from the vein during stasis or as decreased fibrinolytic activity in the vein wall as determined histochemically, was found in 26 out of 53 patients studied (49%). It is concluded that deep venous thrombosis of the upper arm is a multifactorial disease. An impaired fibrinolytic defence mechanism is one of the factors that may be of pathogenetic importance.

Full text

PDF
265

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Astedt B., Isacson S., Nilsson I. M., Pandolfi M. Thrombosis and oral contraceptives: possible predisposition. Br Med J. 1973 Dec 15;4(5893):631–634. doi: 10.1136/bmj.4.5893.631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hedner U., Nilsson I. M., Isacson S. Effect of ethyloestrenol on fibrinolysis in the vessel wall. Br Med J. 1976 Sep 25;2(6038):729–731. doi: 10.1136/bmj.2.6038.729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hedner U., Nilsson I. M., Jacobsen C. D. Demonstration of low content of fibrinolytic inhibitors in individuals with high fibrinolytic capacity. Scand J Clin Lab Invest. 1970 Jun;25(4):329–336. doi: 10.3109/00365517009046213. [DOI] [PubMed] [Google Scholar]
  4. Isacson S., Nilsson I. M. Defective fibrinolysis in blood and vein walls in recurrent "idiopathic" venous thrombosis. Acta Chir Scand. 1972;138(4):313–319. [PubMed] [Google Scholar]
  5. Johansson L., Hedner U., Nilsson I. M. Familial antithrombin III deficiency as pathogenesis of deep venous thrombosis. Acta Med Scand. 1978;204(6):491–495. doi: 10.1111/j.0954-6820.1978.tb08478.x. [DOI] [PubMed] [Google Scholar]
  6. Nilsson B., Nilsson I. M., Hedner U. delta 4-ethylestrenol in recurrent deep venous thrombosis. Acta Med Scand. 1981;209(1-2):45–49. doi: 10.1111/j.0954-6820.1981.tb11550.x. [DOI] [PubMed] [Google Scholar]
  7. Nilsson I. M., Hedner U., Isacson S. Phenformin and ethyloestrenol in recurrent venous thrombosis. Acta Med Scand. 1975 Jul-Aug;198(1-2):107–113. doi: 10.1111/j.0954-6820.1975.tb19513.x. [DOI] [PubMed] [Google Scholar]
  8. Nilsson I. M., Kirkwood T. B., Barrowcliffe T. W. In vivo recovery of factor VIII: a comparison of one-stage and two-stage assay methods. Thromb Haemost. 1979 Dec 21;42(4):1230–1239. [PubMed] [Google Scholar]
  9. Pandolfi M. Histochemistry and assay of plasminogen activator. Rev Eur Etud Clin Biol. 1972 Mar;17(3):254–260. [PubMed] [Google Scholar]
  10. Robertson B. R., Pandolfi M., Nilsson I. M. "Fibrinolytic capacity" in healthy volunteers as estimated from effect of venous occlusion of arms. Acta Chir Scand. 1972;138(5):429–436. [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES